Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Adaptive Biotechnologies Corporation (ADPT) had Free Cash Flow per Share of $-0.28 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$58.88M |
|
$-25.61M |
|
$18.00M |
|
$40.88M |
|
$83.92M |
|
$-25.04M |
|
$-0.56M |
|
$-25.59M |
|
$-25.59M |
|
$-25.59M |
|
$-25.59M |
|
$-25.59M |
|
$-25.59M |
|
$-25.04M |
|
$-21.28M |
|
152.08M |
|
152.08M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$261.86M |
|
$41.05M |
|
$234.78M |
|
$496.64M |
|
$92.14M |
|
-- |
|
$224.96M |
|
$317.10M |
|
$179.54M |
|
$57.98M |
|
$179.54M |
|
152.24M |
|
| Cash Flow Statement Financials | |
$-40.91M |
|
$28.92M |
|
$7.06M |
|
$50.82M |
|
$45.88M |
|
$-4.93M |
|
$25.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
69.43% |
|
-42.52% |
|
-42.52% |
|
-- |
|
-43.47% |
|
-43.50% |
|
$-42.83M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
2.14 |
|
1.33 |
|
67.69 |
|
-14.26% |
|
-44.14% |
|
-5.15% |
|
-14.26% |
|
$1.18 |
|
|
Free Cash Flow per Share |
$-0.28 |
$-0.27 |
|